186 related articles for article (PubMed ID: 30066293)
1. Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs.
De Pieri A; Ribeiro S; Tsiapalis D; Eglin D; Bohner M; Dubruel P; Procter P; Zeugolis DI; Bayon Y
J Mater Sci Mater Med; 2018 Jul; 29(8):129. PubMed ID: 30066293
[TBL] [Abstract][Full Text] [Related]
2. Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.
Coentro JQ; De Pieri A; Gaspar D; Tsiapalis D; Zeugolis DI; Bayon Y
J Mater Sci Mater Med; 2019 Dec; 30(12):133. PubMed ID: 31792698
[TBL] [Abstract][Full Text] [Related]
3. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
Hafner J
J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
[TBL] [Abstract][Full Text] [Related]
5. Innovating in the medical device industry - challenges & opportunities ESB 2015 translational research symposium.
Bayon Y; Bohner M; Eglin D; Procter P; Richards RG; Weber J; Zeugolis DI
J Mater Sci Mater Med; 2016 Sep; 27(9):144. PubMed ID: 27552808
[TBL] [Abstract][Full Text] [Related]
6. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
7. NIMH initiatives to facilitate collaborations among industry, academia, and government for the discovery and clinical testing of novel models and drugs for psychiatric disorders.
Brady LS; Winsky L; Goodman W; Oliveri ME; Stover E
Neuropsychopharmacology; 2009 Jan; 34(1):229-43. PubMed ID: 18800066
[TBL] [Abstract][Full Text] [Related]
8. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
9. Relationships between academic institutions and industry in the life sciences--an industry survey.
Blumenthal D; Causino N; Campbell E; Louis KS
N Engl J Med; 1996 Feb; 334(6):368-73. PubMed ID: 8538709
[TBL] [Abstract][Full Text] [Related]
10. A prospective view on European pharmaceutical research and development. Policy options to reduce fragmentation and increase competitiveness.
Kanavos P
Pharmacoeconomics; 1998 Feb; 13(2):181-90. PubMed ID: 10178646
[TBL] [Abstract][Full Text] [Related]
11. Academic-industry Collaborations in Translational Stroke Research.
Boltze J; Wagner DC; Barthel H; Gounis MJ
Transl Stroke Res; 2016 Aug; 7(4):343-53. PubMed ID: 27301976
[TBL] [Abstract][Full Text] [Related]
12. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.
Galis ZS; Black JB; Skarlatos SI
Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235
[TBL] [Abstract][Full Text] [Related]
13. Academic collaborations with industry: lessons for the future.
Reddy SSK; Chao S
J Investig Med; 2020 Dec; 68(8):1305-1308. PubMed ID: 33168581
[TBL] [Abstract][Full Text] [Related]
14. The academic-industrial complex: navigating the translational and cultural divide.
Freedman S; Mullane K
Drug Discov Today; 2017 Jul; 22(7):976-993. PubMed ID: 28336175
[TBL] [Abstract][Full Text] [Related]
15. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
[TBL] [Abstract][Full Text] [Related]
16. The changing roles of industry and academia.
Bauer EA; Cohen DE
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
[TBL] [Abstract][Full Text] [Related]
17. Translational medicine in neuromuscular disorders: from academia to industry.
Cowling BS; Thielemans L
Dis Model Mech; 2019 Oct; 13(2):. PubMed ID: 31658990
[TBL] [Abstract][Full Text] [Related]
18. Progressing innovation in biomaterials. From the bench to the bed of patients.
Bayon Y; Bohner M; Eglin D; Thérin M; Montali A; Procter P; Fisher J; Richards RG
J Mater Sci Mater Med; 2015 Sep; 26(9):228. PubMed ID: 26329819
[TBL] [Abstract][Full Text] [Related]
19. Translational research: the changing landscape of drug discovery.
Fishburn CS
Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
[TBL] [Abstract][Full Text] [Related]
20. Translational research in academia and industry.
Clackson T
Exp Biol Med (Maywood); 2006 Dec; 231(11):1685-9. PubMed ID: 17138754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
